PEDIATRIC SOLID TUMOR
Clinical trials for PEDIATRIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for PEDIATRIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for children and young adults (up to age 26) with solid tumors that have come back or not responded to standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a protein called B…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
New hope for kids with hard-to-treat cancers: experimental drug CLR 131 enters human testing
Disease control OngoingThis early-phase study tests an experimental drug called CLR 131 in 30 children, adolescents, and young adults whose solid tumors, lymphoma, or brain tumors have returned or not responded to standard treatments. The main goal is to find a safe dose and check for side effects. Par…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Engineered immune cells take aim at childhood cancers in early trial
Disease control OngoingThis early-stage study tests a personalized cell therapy for children and young adults (ages 1–30) with solid tumors that have come back or not responded to treatment. The therapy uses the patient's own immune cells, modified to recognize and attack tumors that carry a protein ca…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Gene testing guides cancer therapy in kids: a step toward precision medicine
Knowledge-focused OngoingThis study looks at whether testing the genes of a child's tumor can help doctors choose a targeted therapy that might work better. It involves children and young adults up to age 30 with solid tumors that have come back or not responded to standard treatment. Researchers will tr…
Matched conditions: PEDIATRIC SOLID TUMOR
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC